Blue Cross Blue Shield of Massachusetts announces new community focus
Blue Cross Blue Shield of Massachusetts (BCBSMA) has announced a new community partner strategy that will focus on four key areas: healthy child development, education enrichment, healthy environments and family nutrition, and sustainable health care.
Blue Cross Blue Shield of Massachusetts (BCBSMA) has announced a new community partner strategy that will focus on four key areas: healthy child development, education enrichment, healthy environments and family nutrition, and sustainable health care. The strategy will direct charitable contributions, volunteer time, and board leadership support toward those four areas.
“After reviewing our community involvement and discussing it with company executives and employees on all levels, as well as a cross section of community leaders, we identified four focus areas that align with our company vision,” said Jeff Bellows in a press statement. Bellows is senior director of Community Relations at BCBSMA. “We will work collaboratively with our partners to improve the health and wellbeing of Massachusetts’ residents, the environment and health care system of the state.”
Last year, BCBSMA employees donated $7.5 million through community work and contributions to local charities, volunteered a total of 14,700 hours at different charitable organizations and assisted with 160 volunteer projects statewide, according to BCBSMA President and CEO Andrew Dreyfus.
BCBSMA is the largest private health plan in Massachusetts, providing coverage to nearly 3 million members.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
July 2nd 2025FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine release syndrome and neurological toxicities.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
